The global threat of counterfeit drugs: why industry and governments must communicate the dangers

The production of substandard and fake drugs is a vast and underreported problem, particularly affecting poorer countries. Cockburn and colleagues argue that the pharmaceutical industry and governments must both take action

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	PLoS medicine 2005-04, Vol.2 (4), p.e100-e100
Hauptverfasser:	Cockburn, Robert, Newton, Paul N, Agyarko, E Kyeremateng, Akunyili, Dora, White, Nicholas J
Format:	Artikel
Sprache:	eng
Schlagworte:	Confidentiality Cooperation Counterfeiting Criminal investigations Drug Industry Drugs Economic Competition Epidemiology/Public Health Fraud Global Health Government Health Policy Humans Information Services International health International organizations Legislation, Drug Mail fraud Medicine in Developing Countries Patient Education as Topic Pharmaceutical industry Policy Forum Public Health Security Measures
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The production of substandard and fake drugs is a vast and underreported problem, particularly affecting poorer countries. Cockburn and colleagues argue that the pharmaceutical industry and governments must both take action
ISSN:	1549-1676 1549-1277 1549-1676
DOI:	10.1371/journal.pmed.0020100